It launched an “affordable drugs” campaignExternal link to pressure the Swiss Federal Council to introduce compulsory licencing, an instrument which allows cheaper generic medications to be introduced to the market despite the existence of a patent.
Public Eye argues the Swiss government has for too long put the interest of the pharmaceutical industry before the needs of the patients both in Switzerland and abroad.
It accused the authorities of being influenced by the “aggressive lobbying carried out by large Basel-based companies,” which are responsible for sky-rocketing prices.
Introducing compulsory licensing in Switzerland would make the Swiss healthcare system more sustainable, “send a strong signal to the international community and allow access to essential drugs for millions of people”, Public Eye wrote.
The appeal is backed by the Swiss Cancer League, numerous experts in the field and well-known Swiss politicians, such as former Federal Councillor Ruth Dreifuss.
More
More
Wanted: Pharma super cops
This content was published on
Have experience in tackling cybercrime, extremism, extortion, blackmail and bribery? If yes, the Swiss pharma industry might want to hear from you.
Has your continent reached its peak or is there still potential for economic growth?
Some regions of the world are on an upward trajectory with the promise of a steadily improving future. Where do you live? And in which direction is your region or continent developing?
Bern biodiversity project brings boost for forest bees
This content was published on
More sunlit areas in forests can boost the number of wild bees – both in overall terms and in terms of species diversity.
Swiss president kicks off National Day celebrations on Rütli meadow
This content was published on
Several hundred people gathered on the Rütli in central Switzerland at midday on Friday to celebrate the national Swiss holiday, before Karin Keller-Sutter addressed the crowd.
US sets deadline for Novartis and other pharma firms to lower prices
This content was published on
US President Donald Trump says he has sent letters to Swiss giant Novartis and other pharma firms calling for lower drug prices in the United States – or face retaliation.
Around 25,000m3 of rockfall registered in Swiss village of Brienz
This content was published on
More rock has come loose in the eastern Swiss village of Brienz than initially assumed following rainfall last weekend, said a new situation report published on Friday.
Swiss government reacts with ‘great regret’ to new US tariffs
This content was published on
The Swiss government says it will continue to strive for a negotiated solution after the United States imposed 39% tariffs on the Alpine country.
Switzerland testing AI tools to make scarecrows more effective
This content was published on
The Swiss agricultural research centre Agroscope is testing an AI system to more effectively prevent damage to agricultural crops caused by crows and rooks.
UN in Geneva calls for reform of tariffs on plastics
This content was published on
The United Nations is calling for a reform of customs tariffs on plastics, which are lower than those imposed on alternatives, ahead of negotiations for a treaty to limit plastic pollution.
Two robots play hide-and-seek in space with Swiss help
This content was published on
Robots developed separately have worked together at the International Space Station (ISS) for the first time, helped in part by a control centre in Switzerland.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Swiss pharma suspected of delaying generic competition
This content was published on
The United States Food and Drug Administration (FDA) lists Novartis and Roche among drug-makers suspected of hindering generic competition.
This content was published on
Each year, some half a million people die of malaria, many of them children. Switzerland is a world leader in research to combat the disease.
This content was published on
Links between parliamentarians in Bern and lobby groups have grown by 20% between 2007 and 2015, according to a new study.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.